Phase I trial of topical gentamicin (AppliGel-G) in patients with new-onset diabetic foot ulcer.

Trial Profile

Phase I trial of topical gentamicin (AppliGel-G) in patients with new-onset diabetic foot ulcer.

Not yet recruiting
Phase of Trial: Phase I

Latest Information Update: 06 Jun 2012

At a glance

  • Drugs Gentamicin (Primary)
  • Indications Bacterial infections; Diabetic foot ulcer; Wound infections
  • Focus Adverse reactions
  • Sponsors Royer Biomedical
  • Most Recent Events

    • 06 Jun 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top